Atlas Trials

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

Clinical trial NCT00608374 · COMPLETED

Trial details

NCT number
NCT00608374
Sponsor
Taunton and Somerset Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lymphoma
Start date
2006-06-01
Primary completion
2009-12-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.